A 1248 New York Assembly · 2025 Regular Session

Prohibits the sale, offer for sale, or delivery of xylazine

Summary

Prohibits the knowing sale, offer for sale, or delivery of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2025

Committee Review

Mar 2026

Assembly Passage

Mar 2026

Senate Passage

Governor

Introduced Jan 9, 2025 Last action Mar 10, 2026

Maddy AI version diff · 3 comparisons

What changed between versions

A1248B → A1248C · 5 edits

MODERATE

This bill was amended to broaden the prohibition on xylazine sales by removing the 50-gram quantity threshold and clarifying the language to cover sale, offer for sale, or delivery. The changes also update the proof requirements for individuals under 21 and modify the record-keeping duration for businesses.

Scope change

The bill's scope was expanded by removing the 50-gram minimum quantity threshold, making the prohibition apply to all quantities of xylazine rather than just larger amounts.

REQUIREMENT

Removed the 50-gram quantity threshold that previously limited the prohibition to sales of fifty grams or more.

Changed the language from 'sale' to 'sale, offer for sale, or delivery' to broaden the scope of prohibited activities.

Added specific language requiring proof of intended use for institutional, veterinary, or scientific purposes, including obtaining a copy of the individual's active veterinary license or affidavit.

Modified the age verification requirement for individuals under 21 to explicitly require government-issued identification by the individual, veterinary representative, or purchasing agent.

Changed the record-keeping requirement from unspecified duration to a minimum of five years for sales records, proof of age, and proof of use.

Floor votes · Assembly May 21, 2025

How they voted

146–0

Passed · 6 other

Total votes 152

May 21, 2025

D Democratic105

100 Yea 5

95% Yea

R Republican47

46 Yea 1

97% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Mar 10, 2026

Committee

REFERRED TO CONSUMER PROTECTION

upper

Mar 10, 2026

Lower · Passed

PASSED ASSEMBLY

lower

Jan 12, 2026

Lower · Passed

AMENDED ON THIRD READING (T) 1248C

lower

May 27, 2025

Committee

RECOMMITTED TO CONSUMER PROTECTION

upper

May 27, 2025

Lower · Passed

REPASSED ASSEMBLY

lower

May 22, 2025

Lower · Passed

AMENDED ON THIRD READING 1248B

lower

May 21, 2025

Committee

REFERRED TO COMMERCE, ECONOMIC DEVELOPMENT AND SMALL BUSINESS

upper

May 21, 2025

Lower · Passed

PASSED ASSEMBLY

lower

May 20, 2025

Committee

REPORTED REFERRED TO RULES

lower

Apr 21, 2025

Lower · Passed

PRINT NUMBER 1248A

lower

Apr 21, 2025

Lower · Passed

AMEND (T) AND RECOMMIT TO WAYS AND MEANS

lower

Apr 2, 2025

Committee

REPORTED REFERRED TO WAYS AND MEANS

lower

Mar 25, 2025

Committee

REPORTED REFERRED TO CODES

lower

Jan 9, 2025

Committee

REFERRED TO CONSUMER AFFAIRS AND PROTECTION

lower

1 primary · 27 co-sponsors